menu
    • menu

    Company profile for United Therapeutics

    NEW Drugs in Dev: 12
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens – having a positive impact on patients, the envi...
    United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens – having a positive impact on patients, the environment and society – will sustain our success in the long term.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    United TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1040 Spring Street Silver Spring, Maryland 20910
    Telephone
    Telephone
    (301) 608-9292
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.unither.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/united-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    United Therapeutics wins RMAT tag for miroliverELAP
    United Therapeutics wins RMAT tag for miroliverELAP

    08 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260408473035/en/United-Therapeutics-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-Designation-for-miroliverELAP-for-Treatment-of-Acute-Liver-Failure

    BUSINESSWIRE
    08 Apr 2026
    Share Share
    United Tyvaso TETON-1 Meets Primary Endpoint In IPF Study
    United Tyvaso TETON-1 Meets Primary Endpoint In IPF Study

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330163294/en/United-Therapeutics-Corporation-Announces-TETON-1-Pivotal-Study-of-Tyvaso-Meets-Primary-Endpoint-for-Treatment-of-Idiopathic-Pulmonary-Fibrosis-Exceeding-Impressive-Treatment-Effect-Seen-in-TETON-2

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    United's Tyvaso Backs Up Case For IPF Expansion With Ph. 3 Win
    United's Tyvaso Backs Up Case For IPF Expansion With Ph. 3 Win

    30 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/united-plots-tyvaso-fda-filing-after-repeat-success-lung-disease-portends-new-ipf-standard

    FIERCE PHARMA
    30 Mar 2026
    Share Share
    United Therapeutics Corporation Announces Full Results
    United Therapeutics Corporation Announces Full Results

    11 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260311495225/en/United-Therapeutics-Corporation-Announces-Full-Results-of-TETON-2-Phase-3-Clinical-Trial-Published-in-The-New-England-Journal-of-Medicine

    BUSSINESSWIRE
    11 Mar 2026
    Share Share
    United Therapeutics Corporation Announces $2 Billion Stock
    United Therapeutics Corporation Announces $2 Billion Stock

    09 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260309711022/en/United-Therapeutics-Corporation-Announces-%242-Billion-Stock-Repurchase-Authorization-and-Enters-into-%241.5-Billion-Accelerated-Share-Repurchase-Program

    BUSSINESSWIRE
    09 Mar 2026
    Share Share
    United Therapeutics' Phase 3 Win Tees Up Filing To Challenge J&J
    United Therapeutics' Phase 3 Win Tees Up Filing To Challenge J&J

    03 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/united-therapeutics-phase-3-win-tees-filing-challenge-jj-cardiac-condition

    FIERCE BIOTECH
    03 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search